![Bitcoin’s Role in a Post-Petrodollar World: Analysis and Outlook](https://i-invdn-com.investing.com/news/Bitcoin_150x108_S_1645008820.jpg)
Please try another search
Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Its natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. The company is developing pharmaceutical preparations of psilocybin doses to help heal psychological trauma and diagnosable disorders, including anxiety, depression, post-traumatic stress disorder, and grief and bereavement. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. The company was founded in 2019 and is based in Toronto, Canada.
Name | Age | Since | Title |
---|---|---|---|
Christopher Michael Bull | - | 2023 | Director |
Jody Aufrichtig | 49 | 2021 | Co-Founder & Executive Chairman |
Warwick Ron Corden-Lloyd | 44 | 2021 | Director |
Alan Mark Friedman | 52 | 2021 | Independent Director |
AC Braddock | - | 2023 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review